SCHEMBL7690136

SCHEMBL7690136

COc1ccccc1N1CCN(CCCCn2nc(C)ccc2=O)CC1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.66
ADRA2A P08913 1/20 0.66
ADRA2B P18089 1/20 0.66
ADRA2C P18825 1/20 0.66
DRD4 P21917 1/20 0.66
HRH2 P25021 1/20 0.66
ADRA1D P25100 1/20 0.66
HTR1D P28221 1/20 0.66
HTR1B P28222 1/20 0.66
HTR2A P28223 1/20 0.66
HTR7 P34969 1/20 0.66
ADRA1A P35348 1/20 0.66
HRH1 P35367 1/20 0.66
ADRA1B P35368 1/20 0.66
HTR2B P41595 1/20 0.66
SIGMAR1 Q99720 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681514 0.93
SCHEMBL8101997 0.86 DRD4 (0.65) HTR1AADRA2AADRA2BADRA2CDRD4
SCHEMBL7681457 0.82 HTR1A (0.60) HTR1AADRA2AADRA2BADRA2CDRD4
SCHEMBL7681588 0.80 HTR1A (0.58) HTR1AHTR2AHTR7
SCHEMBL8103431 0.80 DRD2 (0.60) HTR1AADRA2AADRA2BADRA2CDRD4
SCHEMBL8103432 0.79 HTR1A (0.64) HTR1AADRA2AADRA2BADRA2CDRD4
SCHEMBL4546508 0.79 HTR1A (1.00) HTR1AADRA2AADRA2BADRA2CDRD4
SCHEMBL8558678 0.79 HTR1A (1.00) HTR1AADRA2AADRA2BADRA2CDRD4
SCHEMBL6526368 0.79 DRD2 (0.85) HTR1AADRA1DHTR2AHTR7ADRA1A
SCHEMBL14761349 0.79 HTR1A (0.79) HTR1AADRA2AADRA2BADRA2CDRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413966-B1 SEROTONERGIC AND CENTRAL DOPAMINERGIC ACTIVITY; AFFINITY FOR 5HT1A AND 5HT2 SEROTONIN AND D2 DOPAMINE RECEPTORS; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA FAES, FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. 2002-07-02 US claimed
EP-1057820-A1 Arylpiperazinylalkyl-3(2H)-pyridazinones as serotonin 5HT and dopamine D2 receptor agonists FAES, Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A. (ES) 2000-12-06 EP claimed